Literature DB >> 30552966

Osteoarthritis year in review 2018: biomarkers (biochemical markers).

F Saberi Hosnijeh1, S M Bierma-Zeinstra2, A C Bay-Jensen3.   

Abstract

OBJECTIVE: The aim of this narrative review is to summarize important findings from biochemical marker studies relevant to osteoarthritis (OA) in the context of new discoveries and clinical and scientific need.
DESIGN: We conducted a systematic search of electronic medical databases (Embase, Medline, Web of Science, Cochrane central) between 01-03-2017 and 31-03-2018. The search was restricted to human studies, English language and full text available publications while reviews were excluded. Only papers describing protein based biomarkers measured in human body fluids (blood, urine and synovial fluid (SF)) were included. Of the 992 papers, 86 were reviewed here, with inclusion primarily based on relevance to OA biochemical markers.
RESULTS: This review highlights a selection of studies based on their quality and perceived importance to the field mainly including those that1 evaluate prognostic value of biomarkers for OA progression (i.e., biomarkers reflecting change in composition of joint tissues and biomarkers of inflammation)2, help in assessment of intervention efficacy, and3 are innovative and uncover new candidate biomarkers, or use new approaches in biomarker discovery.
CONCLUSIONS: Key findings and implications for possible clinical utility of biochemical markers are summarized and discussed. Given the paucity of robust biomarkers within the field, and the heterogeneity of the condition, enormous works are needed for development and validation of novel and clinically applicable biomarkers to reduce the impact of this highly prevalent and debilitating condition.
Copyright © 2018 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomarker; Diagnosis; Osteoarthritis; Outcome; Prognosis

Mesh:

Substances:

Year:  2018        PMID: 30552966     DOI: 10.1016/j.joca.2018.12.002

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  17 in total

1.  Intra-articular Injection of Mesenchymal Stem Cells after High Tibial Osteotomy in Osteoarthritic Knee: Two-Year Follow-up of Randomized Control Trial.

Authors:  Jun-Ho Kim; Kang-Il Kim; Wan Keun Yoon; Sang-Jun Song; Wook Jin
Journal:  Stem Cells Transl Med       Date:  2022-06-08       Impact factor: 7.655

2.  Inflammatory, Structural, and Pain Biochemical Biomarkers May Reflect Radiographic Disc Space Narrowing: The Johnston County Osteoarthritis Project.

Authors:  Adam P Goode; Todd A Schwartz; Virginia B Kraus; Janet L Huebner; Steven Z George; Rebecca J Cleveland; Richard Gracely; Maria Jimenez; Louis E DeFrate; Jun Chen; Yvonne M Golightly; Joanne M Jordan
Journal:  J Orthop Res       Date:  2019-12-04       Impact factor: 3.494

3.  Autofluorescence Lifetime Reports Cartilage Damage in Osteoarthritis.

Authors:  João L Lagarto; Mohammad B Nickdel; Douglas J Kelly; Andrew Price; Jagdeep Nanchahal; Chris Dunsby; Paul French; Yoshifumi Itoh
Journal:  Sci Rep       Date:  2020-02-07       Impact factor: 4.379

4.  Protease-activated receptor 2 (PAR-2) antagonist AZ3451 as a novel therapeutic agent for osteoarthritis.

Authors:  Xiaojian Huang; Bowei Ni; Yang Xi; Xiangyu Chu; Rui Zhang; Hongbo You
Journal:  Aging (Albany NY)       Date:  2019-12-16       Impact factor: 5.682

5.  Skeletal stem cell-mediated suppression on inflammatory osteoclastogenesis occurs via concerted action of cell adhesion molecules and osteoprotegerin.

Authors:  Xin Li; Li Ding; Yu-Xing Wang; Zhong-Li Li; Qian Wang; Zhi-Dong Zhao; Sen Zhao; Hua Wang; Chu-Tse Wu; Ning Mao; Heng Zhu
Journal:  Stem Cells Transl Med       Date:  2019-11-27       Impact factor: 6.940

6.  Metabolic Syndrome and Its Effects on Cartilage Degeneration vs Regeneration: A Pilot Study Using Osteoarthritis Biomarkers.

Authors:  Rajath Siddaramanna Onkarappa; Devendra Kumar Chauhan; Biman Saikia; Adil Karim; Rajendra Kumar Kanojia
Journal:  Indian J Orthop       Date:  2020-07-24       Impact factor: 1.251

7.  Baicalin Protects Human OA Chondrocytes Against IL-1β-Induced Apoptosis and ECM Degradation by Activating Autophagy via MiR-766-3p/AIFM1 Axis.

Authors:  Zhi Li; Jiangqi Cheng; Jiuxiang Liu
Journal:  Drug Des Devel Ther       Date:  2020-07-07       Impact factor: 4.162

8.  Nociceptin is present in synovial fluid of patients undergoing total knee arthroplasty.

Authors:  Thomas A Verbeek; Nancy Ruth Jarbadan; Charles Davis; Julia Caldwell
Journal:  J Orthop Surg Res       Date:  2020-07-16       Impact factor: 2.359

9.  Mangiferin Prevents TBHP-Induced Apoptosis and ECM Degradation in Mouse Osteoarthritic Chondrocytes via Restoring Autophagy and Ameliorates Murine Osteoarthritis.

Authors:  Yao Li; Yaosen Wu; Kaixia Jiang; Wen Han; Jing Zhang; Lin Xie; Yanlong Liu; Jian Xiao; Xiangyang Wang
Journal:  Oxid Med Cell Longev       Date:  2019-10-15       Impact factor: 6.543

Review 10.  Nanotechnological Strategies for Osteoarthritis Diagnosis, Monitoring, Clinical Management, and Regenerative Medicine: Recent Advances and Future Opportunities.

Authors:  Reza Mohammadinejad; Milad Ashrafizadeh; Abbas Pardakhty; Ilona Uzieliene; Jaroslav Denkovskij; Eiva Bernotiene; Lauriane Janssen; Gabriela S Lorite; Simo Saarakkala; Ali Mobasheri
Journal:  Curr Rheumatol Rep       Date:  2020-04-04       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.